Literature DB >> 17766375

The dominant-negative effect of the Q218K variant of the prion protein does not require protein X.

Cheng I Lee1, Qingyuan Yang, Veronique Perrier, Ilia V Baskakov.   

Abstract

Previous studies identified several single-point mutants of the prion protein that displayed dominant-negative effects on prion replication. The dominant-negative effect was assumed to be mediated by protein X, an as-yet-unknown cellular cofactor that is believed to be essential for prion replication. To gain insight into the mechanism that underlies the dominant-negative phenomena, we evaluated the effect of the Q218K variant of full-length recombinant prion protein (Q218K rPrP), one of the dominant-negative mutants, on cell-free polymerization of wild-type rPrP into amyloid fibrils. We found that both Q218K and wild-type (WT) rPrPs were incorporated into fibrils when incubated as a mixture; however, the yield of polymerization was substantially decreased in the presence of Q218K rPrP. Furthermore, in contrast to fibrils produced from WT rPrP, the fibrils generated in the mixture of WT and Q218K rPrPs did not acquire the proteinase K-resistant core of 16 kDa that was shown previously to encompass residues 97-230 and was similar to that of PrP(Sc). Our studies demonstrate that the Q218K variant exhibits the dominant-negative effect in cell-free conversion in the absence of protein X, and that this effect is, presumably, mediated by physical interaction between Q218K and WT rPrP during the polymerization process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766375      PMCID: PMC2204135          DOI: 10.1110/ps.072954607

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  20 in total

1.  Autocatalytic conversion of recombinant prion proteins displays a species barrier.

Authors:  Ilia V Baskakov
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

2.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

3.  Amino acid polymorphisms of PrP with reference to onset of scrapie in Suffolk and Corriedale sheep in Japan.

Authors:  T Ikeda; M Horiuchi; N Ishiguro; Y Muramatsu; G D Kai-Uwe; M Shinagawa
Journal:  J Gen Virol       Date:  1995-10       Impact factor: 3.891

4.  Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland.

Authors:  N Hunter; L Moore; B D Hosie; W S Dingwall; A Greig
Journal:  Vet Rec       Date:  1997-01-18       Impact factor: 2.695

5.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation.

Authors:  K Kaneko; L Zulianello; M Scott; C M Cooper; A C Wallace; T L James; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

6.  Elimination of prions by branched polyamines and implications for therapeutics.

Authors:  S Supattapone; H O Nguyen; F E Cohen; S B Prusiner; M R Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Authors:  C Korth; B C May; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Probing the instabilities in the dynamics of helical fragments from mouse PrPC.

Authors:  Ruxandra I Dima; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-19       Impact factor: 11.205

9.  Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPSc replication in vitro.

Authors:  Hitaru Kishida; Yuji Sakasegawa; Kota Watanabe; Yoshio Yamakawa; Masahiro Nishijima; Yoshiyuki Kuroiwa; Naomi S Hachiya; Kiyotoshi Kaneko
Journal:  Amyloid       Date:  2004-03       Impact factor: 7.141

10.  Dominant-negative inhibition of prion replication in transgenic mice.

Authors:  Véronique Perrier; Kiyotoshi Kaneko; Jiri Safar; Julie Vergara; Patrick Tremblay; Stephen J DeArmond; Fred E Cohen; Stanley B Prusiner; Andrew C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

View more
  24 in total

Review 1.  Elucidating the role of cofactors in mammalian prion propagation.

Authors:  Surachai Supattapone
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

2.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

3.  Requirements for mutant and wild-type prion protein misfolding in vitro.

Authors:  Geoffrey P Noble; Daniel J Walsh; Michael B Miller; Walker S Jackson; Surachai Supattapone
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

4.  Role of the goat K222-PrP(C) polymorphic variant in prion infection resistance.

Authors:  Patricia Aguilar-Calvo; Juan Carlos Espinosa; Belén Pintado; Alfonso Gutiérrez-Adán; Elia Alamillo; Alberto Miranda; Irene Prieto; Alex Bossers; Olivier Andreoletti; Juan María Torres
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models.

Authors:  Alicia Otero; Carlos Hedman; Natalia Fernández-Borges; Hasier Eraña; Belén Marín; Marta Monzón; Manuel A Sánchez-Martín; Romolo Nonno; Juan José Badiola; Rosa Bolea; Joaquín Castilla
Journal:  Mol Neurobiol       Date:  2019-03-07       Impact factor: 5.590

Review 6.  The prion hypothesis: from biological anomaly to basic regulatory mechanism.

Authors:  Mick F Tuite; Tricia R Serio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11-17       Impact factor: 94.444

7.  An Amino Acid Substitution Found in Animals with Low Susceptibility to Prion Diseases Confers a Protective Dominant-Negative Effect in Prion-Infected Transgenic Mice.

Authors:  Alicia Otero; Rosa Bolea; Carlos Hedman; Natalia Fernández-Borges; Belén Marín; Óscar López-Pérez; Tomás Barrio; Hasier Eraña; Manuel A Sánchez-Martín; Marta Monzón; Juan José Badiola; Joaquín Castilla
Journal:  Mol Neurobiol       Date:  2017-12-20       Impact factor: 5.590

8.  A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation.

Authors:  Laura Westergard; Jessie A Turnbaugh; David A Harris
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 9.  Heterozygous inhibition in prion infection: the stone fence model.

Authors:  Atsushi Kobayashi; Masaki Hizume; Kenta Teruya; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Prion       Date:  2009-01-23       Impact factor: 3.931

10.  Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.

Authors:  James C Geoghegan; Michael B Miller; Aimee H Kwak; Brent T Harris; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.